Literature DB >> 9413150

Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor PAX8.

S M Hewitt1, S Hamada, A Monarres, L V Kottical, G F Saunders, T J McDonnell.   

Abstract

The bcl-2 proto-oncogene suppresses apoptosis in a variety of cell types and is essential for normal renal development. PAX8 is a member of the paired box class of transcription factors and is developmentally regulated. bcl-2 and PAX8 are both expressed in the kidney during development and throughout life, demonstrating a nearly identical pattern of expression. We used transient transfection reporter assays and electrophoretic mobility shift assays to test PAX8 transcriptional regulation of bcl-2. PAX8 transcriptionally activates the bcl-2 promoter and binds to promoter sequences in vitro. These findings establish that PAX8 can transcriptionally regulate bcl-2 and suggest that suppression of apoptosis is an important event in the development and maintenance of renal tubular epithelial structures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413150

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.

Authors:  Sophia Boyoung Lee; Kai Doberstein; Peter Baumgarten; Anja Wieland; Christopher Ungerer; Claudia Bürger; Katja Hardt; Wolf-Henning Boehncke; Josef Pfeilschifter; Daniela Mihic-Probst; Michel Mittelbronn; Paul Gutwein
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

2.  Gene expression profiling at early organogenesis reveals both common and diverse mechanisms in foregut patterning.

Authors:  Henrik Fagman; Elena Amendola; Luca Parrillo; Pietro Zoppoli; Pina Marotta; Marzia Scarfò; Pasquale De Luca; Denise Pires de Carvalho; Michele Ceccarelli; Mario De Felice; Roberto Di Lauro
Journal:  Dev Biol       Date:  2011-09-01       Impact factor: 3.582

3.  Increased paired box transcription factor 8 has a survival function in glioma.

Authors:  Noelyn Hung; Yu-Jen Chen; Ahmad Taha; Magnus Olivecrona; Ronald Boet; Anna Wiles; Tracy Warr; Alisha Shaw; Ramona Eiholzer; Bruce C Baguley; Michael R Eccles; Antony W Braithwaite; Martin Macfarlane; Janice A Royds; Tania Slatter
Journal:  BMC Cancer       Date:  2014-03-06       Impact factor: 4.430

Review 4.  PAX8, an Emerging Player in Ovarian Cancer.

Authors:  Priyanka Gokulnath; Amata Amy Soriano; Tiziana de Cristofaro; Tina Di Palma; Mariastella Zannini
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.

Authors:  Rajani Kanteti; Essam El-Hashani; Immanuel Dhanasingh; Maria Tretiakova; Aliya N Husain; Sherven Sharma; Jay Sharma; Everett E Vokes; Ravi Salgia
Journal:  BMC Cancer       Date:  2014-03-14       Impact factor: 4.430

6.  Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.

Authors:  Laura H Rodgers; Eoghainín Ó hAinmhire; Alexandria N Young; Joanna E Burdette
Journal:  Oncotarget       Date:  2016-05-31

7.  Polymorphism in lncRNA AC016683.6 and its interaction with smoking exposure on the susceptibility of lung cancer.

Authors:  Juan Li; Hang Li; Xiaoting Lv; Zitai Yang; Min Gao; Yanhong Bi; Ziwei Zhang; Shengli Wang; Zhigang Cui; Baosen Zhou; Zhihua Yin
Journal:  Cancer Cell Int       Date:  2018-07-04       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.